Imaging Diagnostic Systems Receives Australian TGA Approval To Market Its CTLM

Main Category: Radiology / Nuclear Medicine
Also Included In: Regulatory Affairs / Drug Approvals;  Medical Devices / Diagnostics
Article Date: 02 Feb 2010 - 22:00 PDT

email to a friend   printer friendly   opinions  

Imaging Diagnostic Systems, Inc., (OTCBB: IMDS), a pioneer in laser optical breast imaging, announced today that the Australian Government Department of Health and Ageing Therapeutic Goods Administration has approved the CT Laser Mammography (CTLM®) system for inclusion on the Australian Register of Therapeutic Goods (ARTG). The Therapeutic Goods Administration (TGA) must approve the inclusion of all medical devices on the Register before devices can be sold in Australia.

"Gaining approval in Australia is an important step for us. It enables us to reach the Australian market and to perhaps influence related markets," stated Deborah O'Brien, IDSI's Senior Vice President. "We are very pleased with the work that our distributor has been doing in this market and anticipate many new developments from this approval."

Approval was obtained through the efforts of Jainsons Pty Ltd., the official distributor of the CTLM system in Australia. Jainsons will now work to introduce the system to the Australian market through commercial and clinical exhibitions, advertising, and the development of clinical studies and partnerships.

"Australia TGA approval will open the well-informed and educated Australian market to the CTLM system," commented Dr. Mukesh Jain, Chairman and CEO of Jainsons. "Once CTLM technology has been introduced and accepted in Australia, the possibility of penetrating Asian countries also emerges, as approval in Australia is of international significance. TGA approval for the CTLM system is indeed a great achievement for IDSI and Jainsons, one that will open new doors for the marketing of this technology."

Source
Imaging Diagnostic Systems, Inc.

• Additional
• References
• Citations